Description

Cjc1295-5mg(without DAC) is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH) that has been widely studied for its ability to influence growth hormone secretion and related biological pathways. CJC-1295 is researched for its potential role in supporting growth hormone signaling, recovery processes, body composition studies, and age-related physiological research.

Key Features

Mechanism: Stimulates growth hormone–releasing hormone pathways and supports endogenous growth hormone secretion
Use: Research applications related to growth hormone activity, recovery, metabolism, and body composition
Route: Subcutaneous injection (under supervised research or clinical protocols)
Properties: Growth hormone pathway modulation, metabolic support, and regenerative research potential

Indications

• Research into growth hormone regulation and endocrine function
• Investigation of muscle recovery and tissue repair pathways
• Supportive studies related to body composition and metabolic processes
• Research applications in healthy aging and physiological performance
• Evaluation of peptide-based approaches for recovery and cellular function

Customer Benefits

• Supports research on growth hormone signaling and regulation
• May contribute to studies involving recovery and tissue maintenance
• Helps advance understanding of metabolic and regenerative pathways
• Provides a valuable compound for peptide and longevity research

Disclaimer: For research and professional use only. Not approved as a medication for diagnosis, treatment, cure, or prevention of diseases unless specifically authorized by regulatory authorities. Use only under appropriate professional supervision.